Vitamin B Niacin Offers No Additional Benefit to Statin Therapy in Seniors Already Diagnosed with Coronary Artery Disease
Johns Hopkins MedicineThe routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows.